Issac Braun - Pluristem Director
| PSTI Stock | ILS 1,922 7.00 0.36% |
Director
Mr. Issac Braun is Independent Director of Pluristem Therapeutics, Inc. Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience. He is a cofounder and was a board member of several hitech startups in the areas of ecommerce, security, messaging, search engines and biotechnology. Mr. Braun is involved with advising private companies on raising capital and business development. since 2014.
| Age | 62 |
| Tenure | 10 years |
| Phone | 972 7 4710 8600 |
| Web | https://pluri-biotech.com/ |
Pluristem Management Efficiency
The company has return on total asset (ROA) of (0.3735) % which means that it has lost $0.3735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8655) %, meaning that it generated substantial loss on money invested by shareholders. Pluristem's management efficiency ratios could be used to measure how well Pluristem manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Rina Baum | Elbit Systems | 73 | |
| Eli Zangvil | Evogene | 45 | |
| Rimon BenShaoul | Nice | 74 | |
| Yocheved Dvir | Nice | 66 | |
| Yoav Doppelt | Tower Semiconductor | 46 | |
| Avraham Guzman | Tower Semiconductor | 79 | |
| Leo Apotheker | Nice | 65 | |
| Ziv Kop | Evogene | 46 | |
| Kinneret Savitzky | Evogene | 45 | |
| Kinneret Savitsky | Evogene | 50 | |
| Sagi Kabla | Tower Semiconductor | 38 | |
| Yoram BenZeev | Elbit Systems | 74 | |
| Gwen Melincoff | Kamada | 67 | |
| Sarit Firon | Evogene | 52 | |
| Dov Ninveh | Elbit Systems | 71 | |
| Reuven Behar | Kamada | 60 | |
| Adina Makover | Evogene | 66 | |
| Ehood Nisan | Elbit Systems | 51 | |
| Dan Falk | Nice | 74 | |
| Ziv Kop | Kamada | 43 | |
| Dalia Rabin | Elbit Systems | 66 | |
Management Performance
| Return On Equity | -0.87 | |||
| Return On Asset | -0.37 |
Pluristem Leadership Team
Elected by the shareholders, the Pluristem's board of directors comprises two types of representatives: Pluristem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pluristem. The board's role is to monitor Pluristem's management team and ensure that shareholders' interests are well served. Pluristem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pluristem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lior Raviv, Chief Officer | ||
| Yaky Yanay, President, CFO, COO, Secretary and Director | ||
| Mark Germain, Director | ||
| Nachum Rosman, Independent Director | ||
| Zalman Aberman, Chairman of the Board, CEO | ||
| Efrat LivneHadass, VP HR | ||
| Yaacov Yanay, CEO Pres | ||
| Israel BenYoram, Independent Director | ||
| Doron Shorrer, Lead Independent Director | ||
| Karine Kleinhaus, Divisional Vice President North-America | ||
| Chen FrancoYehuda, CFO, Treasurer, Secretary | ||
| Nimrod Zvi, Chief Officer | ||
| Issac Braun, Director | ||
| Erez Egozi, CFO | ||
| Hava Meretzki, Director | ||
| Moria Kwiat, Director | ||
| Nitsan MD, Chief Officer |
Pluristem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pluristem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.87 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (202.13) % | |||
| Current Valuation | 9.75 M | |||
| Shares Outstanding | 32.35 M | |||
| Shares Owned By Insiders | 7.28 % | |||
| Shares Owned By Institutions | 12.80 % | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 499.87 X | |||
| Gross Profit | 23 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pluristem in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pluristem's short interest history, or implied volatility extrapolated from Pluristem options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pluristem using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pluristem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Pluristem Stock analysis
When running Pluristem's price analysis, check to measure Pluristem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pluristem is operating at the current time. Most of Pluristem's value examination focuses on studying past and present price action to predict the probability of Pluristem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pluristem's price. Additionally, you may evaluate how the addition of Pluristem to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |